Early release of HMGB-1 from neurons after the onset of brain ischemia (Q46901701)

26 December 2017

title

Early release of HMGB-1 from neurons after the onset of brain ischemia (English)

1 reference

26 December 2017

author

Salvatore Salomone

7

1 reference

26 December 2017

author name string

Jianhua Qiu

1

1 reference

26 December 2017

Masaki Nishimura

2

1 reference

26 December 2017

Yumei Wang

3

1 reference

26 December 2017

John R Sims

4

1 reference

26 December 2017

Sumei Qiu

5

1 reference

26 December 2017

Sean I Savitz

6

1 reference

26 December 2017

Michael A Moskowitz

8

1 reference

26 December 2017

publication date

14 November 2007

1 reference

26 December 2017

Journal of Cerebral Blood Flow & Metabolism

published in

1 reference

26 December 2017

volume

28

1 reference

26 December 2017

page(s)

927-938

1 reference

26 December 2017

issue

5

1 reference

26 December 2017

MEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemia

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

Cultured astrocytes express toll-like receptors for bacterial products.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

Bacterial endotoxin stimulates macrophages to release HMGB1 partly through CD14- and TNF-dependent mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

Cerebral microvessel responses to focal ischemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

Use of anti-ICAM-1 therapy in ischemic stroke: results of the Enlimomab Acute Stroke Trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

High mobility group box 1 protein is released by neural cells upon different stresses and worsens ischemic neurodegeneration in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

Bacterial lipopolysaccharide activates NF-kappaB through toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells. Differential expression of TLR-4 and TLR-2 in endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

Expression of a dominant negative mutant of interleukin-1 beta converting enzyme in transgenic mice prevents neuronal cell death induced by trophic factor withdrawal and ischemic brain injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

Neuroprotection with the CXCL8 inhibitor repertaxin in transient brain ischemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

Combined oxygen and glucose deprivation in cortical cell culture: calcium-dependent and calcium-independent mechanisms of neuronal injury.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

Microglia and macrophages are the major source of tumor necrosis factor in permanent middle cerebral artery occlusion in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

Neuronal protection in stroke by an sLex-glycosylated complement inhibitory protein.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

The receptor for advanced glycation end-products (RAGE) directly binds to ERK by a D-domain-like docking site

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

Neutrophil infiltration increases matrix metalloproteinase-9 in the ischemic brain after occlusion/reperfusion of the middle cerebral artery in rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

Increased expression of the DNA-binding cytokine HMGB1 in human atherosclerotic lesions: role of activated macrophages and cytokines.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

Toll-like receptor 2 participates in mediation of immune response in experimental pneumococcal meningitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

Matrix metalloproteinase-9 expression in post-hypoxic human brain capillary endothelial cells: H2O2 as a trigger and NF-kappaB as a signal transducer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

Acute Stroke Therapy by Inhibition of Neutrophils (ASTIN): an adaptive dose-response study of UK-279,276 in acute ischemic stroke.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

Microglial-macrophage synthesis of tumor necrosis factor after focal cerebral ischemia in mice is strain dependent.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

A quantitative study of microglial-macrophage synthesis of tumor necrosis factor during acute and late focal cerebral ischemia in mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

Sp1-binding elements in the promoter of RAGE are essential for amphoterin-mediated gene expression in cultured neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

Therapeutic potential of TACE inhibitors in stroke

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

Human blood-brain barrier receptors for Alzheimer's amyloid-beta 1- 40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

Matrix metalloproteinase-9 and myeloperoxidase expression: quantitative analysis by antigen immunohistochemistry in a model of transient focal cerebral ischemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

To be or not to be (inflamed)--is that the question in anti-inflammatory drug therapy of neurodegenerative disorders?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

Intravenous administration of MEK inhibitor U0126 affords brain protection against forebrain ischemia and focal cerebral ischemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

Activation of gene expression in human neutrophils by high mobility group box 1 protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

Regenerative response in ischemic brain restricted by p21cip1/waf1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

Upregulation of the Fas receptor death-inducing signaling complex after traumatic brain injury in mice and humans.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

Inflammatory gene expression in focal cortical brain ischemia: differences between rats and mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

NK/iDC interaction results in IL-18 secretion by DCs at the synaptic cleft followed by NK cell activation and release of the DC maturation factor HMGB1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

HMGB1 and HMGB2 cell-specifically down-regulate the p53- and p73-dependent sequence-specific transactivation from the human Bax gene promoter

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

EGF amplifies the replacement of parvalbumin-expressing striatal interneurons after ischemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

HMG1 and 2: architectural DNA-binding proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

High mobility group 1 B-box mediates activation of human endothelium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

Interferon-beta prevents cytokine-induced neutrophil infiltration and attenuates blood-brain barrier disruption.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

HMG-1 as a late mediator of endotoxin lethality in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

Lipid unites disparate syndromes of sepsis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

Interleukin-1 receptor and receptor antagonist gene expression after focal stroke in rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

Triggers and mediators of hemorrhagic transformation in cerebral ischemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

Significant neuroprotection against ischemic brain injury by inhibition of the MEK1 protein kinase in mice: exploration of potential mechanism associated with apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

Activation of mitogen-activated protein kinases after permanent cerebral artery occlusion in mouse brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

Expression of tumor necrosis factor-alpha and intercellular adhesion molecule-1 after focal cerebral ischemia in interleukin-1beta converting enzyme deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

Reversing established sepsis with antagonists of endogenous high-mobility group box 1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

The cytokine activity of HMGB1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600582

7 January 2021

Identifiers

DOI

10.1038/SJ.JCBFM.9600582

1 reference

26 December 2017

release_iv4hp3r6rfeyhkufkp5bh6fpya

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/iv4hp3r6rfeyhkufkp5bh6fpya

24 November 2022

mapped directly with Wikidata item

PubMed ID

18000511

1 reference

26 December 2017